{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:29:48Z","timestamp":1787758188601,"version":"build-2784847793"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:p>Depression is currently the fourth leading cause of disease or disability worldwide. Antidepressant is approved for the treatment of major depression (including paediatric depression), obsessive-compulsive disorder (in both adult and paediatric populations), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. Antidepressant is a psychiatric medication used to alleviate mood disorders, such as major depression and dysthymia and anxiety disorders such as social anxiety disorder. Many drugs produce an antidepressant effect, but restrictions on their use have caused controversy and off-label prescription a risk, despite claims of superior efficacy. Our current understanding of its pathogenesis is limited and existing treatments are inadequate, providing relief to only a subset of people suffering from depression. Reviews of literature suggest that heterocyclic moieties and their derivatives has proven success in treating depression.<\/jats:p>","DOI":"10.4103\/0975-7406.80765","type":"journal-article","created":{"date-parts":[[2011,5,28]],"date-time":"2011-05-28T10:00:51Z","timestamp":1306576851000},"page":"194-212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":99,"title":["Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review"],"prefix":"10.4103","volume":"3","author":[{"given":"Nadeem","family":"Siddiqui","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Andalip","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Bawa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhi","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obaid","family":"Afzal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jawaid","family":"Akhtar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishmillah","family":"Azad","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard University, Hamdard Nagar, New Delhi - 110 062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","first-page":"143","article-title":"Synthesis and evaluation of Antidepressant like Activity of Some Novel Thieno-1,2,3-triazine 4-ones","volume":"1","author":"Srinath","year":"2010","journal-title":"Int J Res Pharm Sci"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.bmcl.2010.07.020","article-title":"Design, synthesis and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain","volume":"20","author":"Lucas","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.bmcl.2009.11.108","article-title":"Synthesis and antidepressant activity of optical isomers of 2-(4-benzylpiperazin-1-yl)-1-(5-chloro-6-methoxynaphthalen-2-yl)propan-1-ol (SIPI5056)","volume":"20","author":"Wenga","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2010.04.003","article-title":"Sigma receptors: Potential targets for a new class of antidepressant drug","volume":"127","author":"Fishback","year":"2010","journal-title":"Pharmacol Ther"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2202-11-10","article-title":"Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition","volume":"11","author":"Aboukhatwa","year":"2010","journal-title":"BMC Neurosci"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ddstr.2006.10.019","article-title":"Allosteric modulation of monoamine transporters-new drug targets in depression","volume":"3","author":"Sanchez","year":"2006","journal-title":"Drug Discov Today Ther Strateg"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1016\/j.bmc.2008.05.006","article-title":"Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter","volume":"16","author":"Ben-Daniel","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1021\/jm0503291","article-title":"Conformationally restricted homotryptamines 2 Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors","volume":"48","author":"Mattson","year":"2005","journal-title":"J Med Chem"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1016\/j.ejmech.2010.05.067","article-title":"Synthesis, antioxidant and DNA cleavage activities of novel indole derivatives","volume":"45","author":"Biradar","year":"2010","journal-title":"Eur J Med Chem"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1016\/j.tet.2008.07.014","article-title":"Synthesis of 4-thiaharmalan analogue 4-aryl-1,3-thiazino[5,6-b]indole derivatives by prevention of rearrangements to position two of the indole moiety","volume":"64","author":"Csom\u00f3s","year":"2008","journal-title":"Tetrahedron"},{"key":"R13-20260605","article-title":"Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression","author":"Farah Idayua","year":"2010","journal-title":"Phytomedicine"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0960-894X(00)00364-4","article-title":"1-[2-[(Heteroaryloxy) heteroaryl]carbamoyl] indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant\/anxiolytic agents","volume":"10","author":"Bromidge","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1016\/j.bmcl.2010.05.100","article-title":"Synthesis, antidepressant evaluation and QSAR studies of novel 2-(5H-[1,2,4] triazino [5,6-b] indol-3-ylthio)-N-(substituted phenyl)acetamides","volume":"20","author":"Shelke","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1016\/j.bmc.2009.09.023","article-title":"Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonistsn: Identifation, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles","volume":"17","author":"Haffernan","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bmcl.2008.11.022","article-title":"1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors","volume":"19","author":"Manning","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/np070371u","article-title":"Secondary metabolites from three florida sponges with antidepressant activity","volume":"71","author":"Kochanowska","year":"2008","journal-title":"J Nat Prod"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1016\/j.bmc.2008.05.075","article-title":"Studies towards the discovery of the next generation of antidepressant. Part 6: Dual 5HT1A receptor and serotonine transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivateves","volume":"16","author":"Zhou","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.bmcl.2008.06.030","article-title":"A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands","volume":"18","author":"Liu","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.bmcl.2007.03.040","article-title":"Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors","volume":"17","author":"Deskus","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1016\/j.bmc.2006.08.039","article-title":"Synthesis and activity of a new class of dual acting norepinephrine and serotonine reuptake inhihibitor: (3-(1H-indole-1-yl)-3-arylpropan-1-amines","volume":"14","author":"Mahaney","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bmcl.2004.12.064","article-title":"Studies towards the next generation of antidepressants. Part 4: Derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor","volume":"15","author":"Evrard","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R24-20260605","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bmcl.2004.10.064","article-title":"N1 arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists","volume":"15","author":"Cole","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bmcl.2005.01.059","article-title":"Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs)","volume":"15","author":"Schmitz","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.bmcl.2005.02.070","article-title":"Binding of isotryptamines and indenes at h5-HT6 serotonin receptors","volume":"15","author":"Kolanos","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.bmcl.2004.01.110","article-title":"A new synthesis of indole 5- carboxylic acids and 6- hydroxyl- indole-5-carboxylic acids in the preparation of an o-hydroxyated of vilazodone","volume":"14","author":"Heinrich","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0960-894X(01)00746-6","article-title":"Studies towards the discovery of the next generation of antidepressant. Part 2: Incorporating a 5HT1A antagonist component into a class of serotonin reuptake inhibitors","volume":"12","author":"Mewshaw","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0960-894X(01)00334-1","article-title":"Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors","volume":"11","author":"Meagher","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/jm9811054","article-title":"5-HT Reuptake inhibitors with 5-HT1B\/1D antagonistic activity: A new approach toward efficient antidepressants","volume":"43","author":"Matzen","year":"2000","journal-title":"J Med Chem"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0223-5234(88)90216-4","article-title":"N-(Indole-3-ylglyoxylyl) dopamine derivatives: Preparation and antidepressant activity","volume":"23","author":"Primofiore","year":"1998","journal-title":"Eur J Med Chem"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0223-5234(98)80039-1","article-title":"Synthesis and antidepressant evaluation of new 3- phenyl-5-sulfonamidoindole derivatives","volume":"33","author":"Ergenc","year":"1998","journal-title":"Eur J Med Chem"},{"key":"R33-20260605","article-title":"Synthesis of formazans from Mannich base of 5-(4-chlorophenyl amino)-2-mercapto-1,3,4-thiadiazole as antimicrobial agents","author":"Sah","year":"2010","journal-title":"Arabian J Chem"},{"key":"R34-20260605","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.bmc.2005.10.012","article-title":"Advances in the synthesis and recent therapeutic applications of 1,2,4-thiadiazole heterocycles","volume":"14","author":"Castro","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"R35-20260605","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/jm001027w","article-title":"Synthesis of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity","volume":"15","author":"Clerici","year":"2001","journal-title":"J Med Chem"},{"key":"R36-20260605","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/jm001027w","article-title":"Synthesis of 2-Amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity","volume":"44","author":"Clerici","year":"2001","journal-title":"J Med Chem"},{"key":"R37-20260605","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1016\/j.bmc.2008.07.056","article-title":"Syntheses and anti-depressant activity of 5-amino-1,3,4- thiadiazole-2-thiol imines and thiobenzyl derivatives","volume":"16","author":"Yusuf","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"R38-20260605","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00044-008-9132-1","article-title":"Synthesis and evaluation of 2-amino-5-sulfanyl-1,3,4-thiadiazole as antidepressant, anxiolytic, and anticonvulsant agents","volume":"18","author":"Pattanayak","year":"2009","journal-title":"Med Chem Res"},{"key":"R39-20260605","article-title":"Synthesis and biological evaluation of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives as antidepressant, anxiolytics and anticonvulsants agents","author":"Sharma","year":"2010","journal-title":"Med Chem Res"},{"key":"R40-20260605","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0014-827X(98)00024-X","article-title":"Synthesis, lipophilicity and biological evaluation of indole-containing derivatives of 1,3,4- thiadiazole and 1,2,4-triazole","volume":"53","author":"Varvaresou","year":"1998","journal-title":"Farmaco"},{"key":"R41-20260605","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ejmech.2007.12.003","article-title":"CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones","volume":"43","author":"Jatav","year":"2008","journal-title":"Eur J Med Chem"},{"key":"R42-20260605","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0960-894X(03)00303-2","article-title":"Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism\/SSRI activities. Part 1","volume":"13","author":"Takeuchi","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"R43-20260605","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bmc.2007.10.018","article-title":"Synthesis of pharmaceutically active compounds containing a disubstituted piperidine framework","volume":"16","author":"K\u00e4llstr\u00f6m","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"R44-20260605","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(95)00155-P","article-title":"Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)","volume":"52","author":"Layer","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"R45-20260605","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.bmcl.2005.11.007","article-title":"Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism\/SSRI activities. Part 5","volume":"16","author":"Takeuchi","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"R46-20260605","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1021\/jm100835q","article-title":"Novel pyridylmethylamines as highly selective 5-HT1A superagonists","volume":"53","author":"Bollinger","year":"2010","journal-title":"J Med Chem"},{"key":"R47-20260605","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.bmcl.2006.02.008","article-title":"N-alkyl-N-arylmethylpiperidin-4-amines: Novel dual inhihibitors of serotonin and norepinephrine reuptake","volume":"16","author":"Boot","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"R48-20260605","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.bmcl.2004.02.088","article-title":"Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropane-2-ols with dual 5HT 1A receptor antagonism\/SSRI activities. Part 4","volume":"14","author":"Rocco","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"R49-20260605","first-page":"513","article-title":"Substituted 4-phenyl-4-(1H-Imidazole-2-yl)-Piperidine derivatives as selective non-peptide delta opiod agonist with antidepressant and anxiolytic activity","volume":"31","author":"Steckler","year":"2006","journal-title":"US Patents"},{"key":"R50-20260605","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1016\/j.bmcl.2007.05.012","article-title":"4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives as non-peptides selective opiod agonist with potential anxiolytic\/ antidepressant properties. Part2","volume":"17","author":"Trabanco","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"R51-20260605","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0223-5234(97)83972-4","article-title":"New N-(benzhydroxyalkyl)-4-(carboxy\/carbamoylmethyl)piperidine derivatives with antidepressant activity","volume":"32","author":"Ahmad","year":"1997","journal-title":"Eur J Med Chem"},{"key":"R52-20260605","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.bmcl.2003.09.002","article-title":"Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism\/SSRI Activities. Part 3","volume":"13","author":"Takeuchi","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"R53-20260605","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/S0960-894X(03)00392-5","article-title":"Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism\/SSRI activities. Part 2","volume":"13","author":"Takeuchi","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"R54-20260605","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1021\/jm00361a009","article-title":"Novel tetracyclic spiropiperidines. 3. 1-Arylspiro[indoline-3,4\u2032-piperidine]s as potential antidepressants","volume":"26","author":"Ong","year":"1983","journal-title":"J Med Chem"},{"key":"R55-20260605","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.euroneuro.2007.02.007","article-title":"Novel sigma (\u03c3) receptor agonists produce Antidepressant like effects in mice","volume":"17","author":"Wang","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"R56-20260605","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm00384a040","article-title":"3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity","volume":"30","author":"Balsamo","year":"1987","journal-title":"J Med Chem"},{"key":"R57-20260605","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1021\/jm050694s","article-title":"Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: Effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors","volume":"48","author":"He","year":"2005","journal-title":"J Med Chem"},{"key":"R58-20260605","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1021\/jm0309349","article-title":"Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters","volume":"46","author":"Orjales","year":"2003","journal-title":"J Med Chem"},{"key":"R59-20260605","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/jm9806906","article-title":"Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors","volume":"42","author":"Vacher","year":"1999","journal-title":"J Med Chem"},{"key":"R60-20260605","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1016\/j.bmcl.2009.10.014","article-title":"Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists","volume":"19","author":"Gray","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"R61-20260605","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1016\/j.bmcl.2010.09.081","article-title":"Arylpiperazine-containing pyrimidine-4-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant","volume":"20","author":"Kim","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R62-20260605","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pbb.2010.10.003","article-title":"Combination of escitalopram and a 5-HT1A receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT2C receptor stimulation; suggestive of antipsychotic potential","volume":"97","author":"Hovels","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"R63-20260605","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/dmd.104.001198","article-title":"CYP2D6 catalyzes 5-hydroxylation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of several psychoactive drugs, in human liver microsomes","volume":"33","author":"Raghavan","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"R64-20260605","first-page":"446","article-title":"Synthesis of some novel piperazine salts and their antimicrobial property against Escherichia coli and Bacillus subtilis","volume":"2","author":"Bishnoi","year":"2010","journal-title":"Der Pharma Chemica"},{"key":"R65-20260605","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bmc.2005.09.060","article-title":"Structure\u2013intrinsic activity relationship studies in the group of 1-imido\/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity","volume":"14","author":"Bojarski","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"R66-20260605","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1016\/j.bmcl.2006.05.051","article-title":"N-(1,2-Diphenylethyl)piperazine: A new class of dual serotonin\/noradrenaline reuptake inhibitor","volume":"16","author":"Jonathan Fray","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"R67-20260605","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bmcl.2010.01.093","article-title":"Arylpiperizine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant","volume":"20","author":"Kang","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R68-20260605","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1016\/j.bmcl.2005.04.077","article-title":"Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drug","volume":"15","author":"Kling","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R69-20260605","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1016\/j.bmc.2004.07.059","article-title":"Novel selective and potent 5-HT reuptake inhibitor with 5-HT1D antagonist activity: Chemistry and pharmacological evaluation of a series of thienopyran derivatives","volume":"12","author":"Torrado","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"R70-20260605","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.bmc.2007.02.018","article-title":"Novel class of arylpiperazine containing N-acylated amino acids: Their Synthesis, 5-HT1A, 5HT2A receptor affinity, and in vivo pharmacological evaluation","volume":"15","author":"Zajdel","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R71-20260605","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/j.bmc.2007.07.029","article-title":"The influence of modifications in imide fragment structure on 5-HT1A and 5-HT7 receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines","volume":"15","author":"Paluchowska","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R72-20260605","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1016\/j.bmc.2008.04.023","article-title":"Preparation of piperazine derivatives as 5-HT 7 receptor antagonists","volume":"16","author":"Yoon","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"R73-20260605","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cclet.2008.01.015","article-title":"Arylpiperazine derivatives of diphenylsulfide: Synthesis and evaluation for dual 5-HT1A\/SSRI activities","volume":"19","author":"Wu","year":"2008","journal-title":"Chin Chem Lett"},{"key":"R74-20260605","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.bmcl.2009.11.108","article-title":"Synthesis and antidepressant activity of optical isomers of 2-(4-benzylpiperazin-1-yl)-1-(5-chloro-6-methoxynaphthalen-2-yl)propan-1-ol(SIPI5056)","volume":"20","author":"Weng","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R76-20260605","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1021\/jm9703552","article-title":"5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine","volume":"40","author":"Jorand-Lebrun","year":"1997","journal-title":"J Med Chem"},{"key":"R77-20260605","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1021\/jm8002262","article-title":"Structure-activity relationships of the cycloalkanol ethylamine scaffold: Discovery of selective norepinephrine reuptake inhibitors","volume":"51","author":"Mahaney","year":"2008","journal-title":"J Med Chem"},{"key":"R78-20260605","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/jpet.104.066472","article-title":"Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined \u03c3 and 5-HT1A ligand: Modulation of neuronal activity in the dorsal raphe nucleus","volume":"310","author":"Bermack","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R79-20260605","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0024-3205(87)90570-4","article-title":"Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase","volume":"40","author":"Naoi","year":"1987","journal-title":"Life Sci"},{"key":"R80-20260605","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.ejmech.2010.04.002","article-title":"Synthesis and biological evaluation of new 2-chloro-3-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)quinoline derivatives via click chemistry approach","volume":"45","author":"Kategaonkar","year":"2010","journal-title":"Eur J Med Chem"},{"key":"R81-20260605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF03189540","article-title":"Isolation, characterisation and synthesis of a new quinidine metabolite","volume":"7","author":"Guentert","year":"1982","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R82-20260605","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/jm980333v","article-title":"3,4-Dihydro-2(1H)-quinolinone as a novel antidepressant drug: Synthesis and pharmacology of 1-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives","volume":"43","author":"Oshiro","year":"2000","journal-title":"J Med Chem"},{"key":"R83-20260605","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1016\/j.bmcl.2005.07.038","article-title":"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors","volume":"15","author":"Beadle","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R84-20260605","article-title":"Antidepressant Azaheterocyclymethyl derivatives of 2, 3- dihydro-1,4- dioxino(2,3-F)quinoline","author":"Tran","journal-title":"US Patent"},{"key":"R85-20260605","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.bmc.2006.10.037","article-title":"Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl)amides: A late- stage diversification approach to potent 5HT1B antagonists","volume":"15","author":"Horchler","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R86-20260605","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm8001444","article-title":"Discovery of potent, orally bioavailable, selective 5-HT1A\/B\/D receptor antagonists","volume":"51","author":"Ward","year":"2008","journal-title":"J Med Chem"},{"key":"R87-20260605","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ejmech.2010.12.002","article-title":"Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur J Med Chem"},{"key":"R88-20260605","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.ejmech.2008.10.020","article-title":"Facile synthesis of bis(4,5-dihydro-1H-pyrazole-1-carboxamides) and their thio-analogues of potential PGE2 inhibitory properties","volume":"44","author":"Barsoum","year":"2009","journal-title":"Eur J Med Chem"},{"key":"R89-20260605","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ardp.200800130","article-title":"Design, synthesis, and in-vivo pharmacological screening of N,3-(substituted diphenyl)-5-phenyl-1H-pyrazoline-1-carbothioamides derivatives","volume":"342","author":"Siddiqui","year":"2009","journal-title":"Arch Pharm (Weinheim)"},{"key":"R90-20260605","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0223-5234(01)01243-0","article-title":"Synthesis of antidepressant activities of some 3,5-diphenyl-2-pyrazolines","volume":"36","author":"Palaska","year":"2001","journal-title":"Eur J Med Chem"},{"key":"R91-20260605","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejmech.2006.09.006","article-title":"Synthesis of studies on antidepressant and anticonvusant activities of some 3-(2-furyl)-pyrazoline derivatives","volume":"42","author":"Ozdemir","year":"2007","journal-title":"Eur J Med Chem"},{"key":"R92-20260605","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s12272-009-1915-5","article-title":"Effect of some 1.3,4- trisubtituted-2-pyrazoline derivatives on depression and anxiety parameters of mice","volume":"32","author":"Can","year":"2009","journal-title":"Arch Pharm Res"},{"key":"R93-20260605","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00044-009-9176-x","article-title":"Evaluation of antidepressant- like effect of 2-pyrazoline derivatives","volume":"19","author":"Gok","year":"2010","journal-title":"Med Chem Res"},{"key":"R94-20260605","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.ejmech.2009.01.032","article-title":"Synthesis of novel pyrazole derivatives and evaluation of their antidepressantand anticonvulsant activities","volume":"44","author":"Abdel-Aziz","year":"2009","journal-title":"Eur J Med Chem"},{"key":"R95-20260605","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.bmcl.2010.03.032","article-title":"The development and SAR of pyrrolidine carboxamide 11\u03b2-HSD1 inhibitors","volume":"20","author":"Cheng","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R96-20260605","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bmcl.2004.02.014","article-title":"Structural determinants for high 5-HT2A receptor affinity of spiro[9,10-dihydroanthracene]-9,3\u00a2-pyrrolidine (SpAMDA)","volume":"14","author":"Peddi","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"R97-20260605","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1016\/j.bmc.2008.07.073","article-title":"Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors","volume":"16","author":"Cheng","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"R98-20260605","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bmcl.2007.12.050","article-title":"The design, synthesis and structure-activity relationships of 1-aryl-4-aminoalkyl isoquinolines: A novel series of CRF-1 receptor antagonists","volume":"18","author":"Yoon","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"R99-20260605","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1471-4159.1981.tb01682.x","article-title":"Noncompetitive amine uptake inhibition by the new antidepressant pridefine","volume":"36","author":"DeMet","year":"1981","journal-title":"J Neurochem"},{"key":"R100-20260605","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0022-3565(25)24541-4","article-title":"Preclinical pharmacological actions of (+\/-)-(1\u2032R\u2217,3R\u2217)-3-phenyl-1-[1\u2032,2\u2032,3\u2032,4\u2032-tetrahydro-5\u2032,6\u2032-methylene-dioxy-1\u2032-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine","volume":"272","author":"Hancock","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R101-20260605","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF00381071","article-title":"\u201cIs phosphodiesterase inhibition a new mechanism of antidepressant action. A double blind double-dummy study between rolipram and desipramine in hospitalized major and\/or endogenous depressives\u201d","volume":"238","author":"Bobon","year":"1988","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"R102-20260605","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1016\/j.bmcl.2008.10.025","article-title":"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin\/norepinephrine\/dopamine reuptake inhibitors","volume":"18","author":"Banwart","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"R103-20260605","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0960-894X(01)80353-X","article-title":"Synthesis and pharmacological characterization of ABT-200:A putative novel antidepressant combining potent \u03b1-2 antagonism with moderate NE uptake inhibition","volume":"4","author":"Zelle","year":"1994","journal-title":"Bioorg Med Chem Lett"},{"key":"R104-20260605","first-page":"29","article-title":"Synthesis and antidepressant activity of N-substituted imidazole-5-caboxamide in forced swimming test model","volume":"7","author":"Hadizadeh","year":"2008","journal-title":"Iran J Pharm Res"},{"key":"R105-20260605","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ejmech.2009.11.053","article-title":"Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity","volume":"45","author":"Czopek","year":"2010","journal-title":"Eur J Med Chem"},{"key":"R106-20260605","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/j.ejmech.2009.07.014","article-title":"Synthesis and preliminary pharmacological evaluation of imidazo(2,1-f)purine-2,4-dione derivatives","volume":"44","author":"Zagorska","year":"2009","journal-title":"Eur J Med Chem"},{"key":"R107-20260605","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pbb.2008.04.016","article-title":"Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats","volume":"90","author":"Ulak","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R108-20260605","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/jm800026x","article-title":"Guanidine and 2-aminoimidazoline aromatic derivatives as \u03b12-adrenoceptor antagonists. 2. Exploring alkyl linkers for new antidepressants","volume":"51","author":"Rodriguez","year":"2008","journal-title":"J Med Chem"},{"key":"R109-20260605","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejmech.2010.10.026","article-title":"Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 3","volume":"46","author":"Herold","year":"2011","journal-title":"Eur J Med Chem"},{"key":"R110-20260605","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pbb.2005.08.003","article-title":"Antidepressant-like antinociceptive-like action of 4-(4\u2032-cholorophenyl)-6-(4\u201c-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice","volume":"82","author":"Rodrigues","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"R111-20260605","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ejmech.2008.09.021","article-title":"Novel 4-aryl-pyrido[1,2-C]pyrimidines with dual SSRI and 5-HT1A activity. Part 1","volume":"44","author":"Herhold","year":"2009","journal-title":"Eur J Med Chem"},{"key":"R112-20260605","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1016\/j.ejmech.2009.07.007","article-title":"Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: Part2","volume":"44","author":"Herhold","year":"2009","journal-title":"Eur J Med Chem"},{"key":"R113-20260605","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1016\/j.bmcl.2010.09.081","article-title":"Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant","volume":"20","author":"Kim","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"R115-20260605","first-page":"621","article-title":"Organic Chrmistry: Stereochemistry and the Chemistry of Natural Product","volume":"2","author":"Finar","year":"2004"},{"key":"R116-20260605","first-page":"311","article-title":"Nefazodone: preclinical pharmacology of a new antidepressant","volume":"26","author":"Eison","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"R117-20260605","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ejmech.2010.01.030","article-title":"Synthesis of 3-((2,4-dichloro phenoxy)methyl)-1,2,4-triazolo(thiadiazoles and thiadiazines) as anti-inflammatory and molluscicidal agents","volume":"45","author":"El Shehry","year":"2010","journal-title":"Eur J Med Chem"},{"key":"R118-20260605","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.ejmech.2010.06.011","article-title":"New Pyrazoline derivatives and their antidepressant activity","volume":"45","author":"Kapilncki","year":"2010","journal-title":"Eur J Med Chem"},{"key":"R119-20260605","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/jm00401a031","article-title":"2,4-Dihydro-3-H-1,2,4-triazole-3-thiones as potential antidepressant agents","volume":"31","author":"Kane","year":"1988","journal-title":"J Med Chem"},{"key":"R120-20260605","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0014-827X(98)00024-X","article-title":"Synthesis, lipophilicity and biological evaluation of indole-containing derivatives of 1,3,4-thiadiazole and 1,2,4-triazole","volume":"53","author":"Varvaresou","year":"1998","journal-title":"Farmaco"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01438291-201103020-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:08:34Z","timestamp":1787756914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01438291-201103020-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4103\/0975-7406.80765","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"2011-02-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-02-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}